Plasmavigilance—Adverse events among US Source plasma donors

BACKGROUND: Source plasma (SP) is the primary starting material for 87% of plasma‐derived medicinal products globally. Plasmavigilance is a program designed to collect, analyze, and monitor donor adverse events (AEs) across the SP collection industry. Donor retention depends on donors having a safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreiber, George B., Becker, Mark, Fransen, Michelle, Hershman, Janet, Lenart, James, Song, Guang, Simon, Toby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Blood Donors and Blood Collection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291118/
https://www.ncbi.nlm.nih.gov/pubmed/34390267
http://dx.doi.org/10.1111/trf.16612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291118/
https://www.ncbi.nlm.nih.gov/pubmed/34390267
http://dx.doi.org/10.1111/trf.16612

Ejemplares similares